Research Departments Physiology Bifunctional protein PCBD2 operates as a co factor
30 March 2021

Lotte Tholen, Jeroen de Baaij and colleagues from theme Renal disorders, published in the FASEB Journal that PCBD1 and PCBD2 exert different effects on HNF1β‐mediated transcription. The project is funded by the Dutch Kidney Foundation.

Hepatocyte nuclear factor 1β (HNF1β) is an essential transcription factor in development of the kidney, liver, and pancreas. HNF1β‐mediated transcription of target genes is dependent on the cell type and the development stage. Nevertheless, the regulation of HNF1β function by enhancers and co‐factors that allow this cell‐specific transcription is largely unknown. 

To map the HNF1β interactome we performed mass spectrometry in a mouse kidney inner medullary collecting duct cell line. Pterin‐4a‐carbinolamine dehydratase 2 (PCBD2) was identified as a novel interaction partner of HNF1β. PCBD2 and its close homolog PCBD1 shuttle between the cytoplasm and nucleus to exert their enzymatic and transcriptional activities. Although both PCBD proteins share high sequence identity (48% and 88% in HNF1 recognition helix), their tissue expression patterns are unique. PCBD1 is most abundant in kidney and liver while PCBD2 is also abundant in lung, spleen, and adipose tissue. 

Using immunolocalization studies and biochemical analysis we show that in presence of HNF1β the nuclear localization of PCBD1 and PCBD2 increases significantly. Promoter luciferase assays demonstrate that co‐factors PCBD1 and PCBD2 differentially regulate the ability of HNF1β to activate the promoters of transcriptional targets important in renal electrolyte homeostasis. Deleting the N‐terminal sequence of PCBD2, not found in PCBD1, diminished the differential effects of the co‐factors on HNF1β activity. 

All together these results indicate that PCBD1 and PCBD2 can exert different effects on HNF1β‐mediated transcription. Future studies should confirm whether these unique co‐factor activities also apply to HNF1β‐target genes involved in additional processes besides ion transport in the kidney.

read more

Related news items


‘Happiness is in the small things’ a throwback to the valedictory lecture of René Bindels

21 June 2022

In a full Aula he outlined his scientific journey of the past 40 years that led to the groundbreaking discovery of the transient receptor potential ion channel TRPV5 that plays an essential role in maintaining the calcium balance in our body.

read more

ERC Starting Grant awarded to Jeroen de Baaij

17 March 2022

Jeroen de Baaij, kidney researcher the Radboudumc, receives an ERC Starting Grant worth 1.5 million euros. He will use this grant to improve the diagnosis and treatment of severe magnesium deficiencies, which can lead to epileptic seizures and muscle cramps.

read more

Academic collaboration agreement between UTwente and Radboudumc

23 November 2021

The group of Biomaterials Science and Technology (BST) of the Faculty of Science and Technology at the TechMed centre of University of Twente has signed a formal academic collaboration agreement with the departments of Nephrology and Physiology at Radboudumc.

read more

Genetic mutations cause severe magnesium deficiency

5 October 2021

Newly discovered errors in DNA change diagnostics and treatment. Jeroen de Baaij tracked down new genetic errors that cause magnesium deficiency and published the findings in the Journal of the American Society of Nephrology.

read more

Jeroen de Baaij Appointed associate professor

1 August 2021

We are happy to announce that Jeroen de Baaij has been appointed associate professor of Kidney Physiology.

read more

Senior Kolff Fellowship for Jeroen de Baaij

29 July 2021

Jeroen de Baaij, theme Renal disorders, received a prestigious Senior Kolff grant from the Dutch Kidney Foundation. His project aims to establish dietary approaches against vascular calcification in chronic kidney disease.

read more